LABCORP HOLDINGS INC. (LH) Operating Margin
- Operating margin · 12 months: Value 10.43%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 10.43% | Operating income / revenue. Period ending 2026-06-30. $1.50B ÷ $14.35B × 100 ≈ 10.43% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.50B USD | Operating Income (Loss) |
| Revenue | 14.35B USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 2.22B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.50B | $14.35B | (m) | (m) | $2.22B | 10.43% |
| 2026-03-31 | $1.44B | $14.14B | (m) | (m) | $2.22B | 10.18% |
| 2025-12-31 | $1.38B | $13.95B | (m) | (m) | $2.22B | 9.92% |
| 2025-09-30 | $1.33B | $13.77B | (m) | (m) | $2.27B | 9.69% |
| 2025-06-30 | $1.19B | $13.48B | (m) | (m) | $2.29B | 8.83% |
| 2025-03-31 | $1.09B | $13.18B | (m) | (m) | $2.27B | 8.28% |
| 2024-12-31 | $1.09B | $13.01B | (m) | (m) | $2.23B | 8.35% |
| 2024-09-30 | $747.40M | $12.71B | (m) | (m) | $2.17B | 5.88% |
| 2024-06-30 | $745.60M | $12.49B | (m) | (m) | $2.12B | 5.97% |
| 2024-03-31 | $717.10M | $12.30B | (m) | (m) | $2.07B | 5.83% |
| 2023-12-31 | $725.60M | $12.16B | (m) | (m) | $2.02B | 5.97% |
| 2023-09-30 | $1.21B | $15.07B | (m) | (m) | $2.18B | 8.06% |
| 2023-06-30 | $1.34B | $14.88B | (m) | (m) | $2.11B | 8.98% |
| 2023-03-31 | $1.43B | $14.76B | (m) | (m) | $2.09B | 9.67% |
| 2022-12-31 | $1.77B | $14.88B | (m) | (m) | $2.00B | 11.92% |
| 2022-09-30 | $2.41B | $15.26B | (m) | (m) | $2.00B | 15.82% |
| 2022-06-30 | $2.71B | $15.72B | (m) | (m) | $2.01B | 17.25% |
| 2022-03-31 | $2.89B | $15.86B | (m) | (m) | $1.99B | 18.22% |
| 2021-12-31 | $3.26B | $16.12B | (m) | (m) | $1.95B | 20.22% |
| 2021-09-30 | $3.82B | $16.55B | (m) | (m) | $1.93B | 23.09% |
| 2021-06-30 | $4.10B | $16.39B | (m) | (m) | $1.83B | 25.03% |
| 2021-03-31 | $3.70B | $15.32B | (m) | (m) | $1.76B | 24.13% |
| 2020-12-31 | $2.45B | $13.98B | (m) | (m) | $1.73B | 17.49% |
| 2020-09-30 | $1.49B | $12.44B | (m) | (m) | $1.63B | 11.96% |
| 2020-06-30 | $781.40M | $11.47B | (m) | (m) | $1.61B | 6.81% |
| 2020-03-31 | $819.40M | $11.59B | (m) | (m) | $1.63B | 7.07% |
| 2019-12-31 | $1.33B | $11.55B | (m) | (m) | $1.62B | 11.51% |
| 2019-09-30 | $1.30B | $11.39B | (m) | (m) | $1.61B | 11.43% |
| 2019-06-30 | $1.30B | $11.29B | (m) | (m) | $1.59B | 11.56% |
| 2019-03-31 | $1.34B | $11.28B | (m) | (m) | $1.57B | 11.87% |
| 2018-12-31 | $1.33B | $11.33B | (m) | (m) | $1.57B | 11.70% |
| 2018-09-30 | $1.41B | (m) | (m) | (m) | $1.90B | (m) |
| 2018-06-30 | $1.39B | (m) | (m) | (m) | $1.90B | (m) |
| 2018-03-31 | $1.35B | (m) | (m) | (m) | $1.87B | (m) |
| 2017-12-31 | $1.36B | (m) | $6.74B | (m) | $1.81B | (m) |
| 2017-09-30 | $1.33B | (m) | $6.56B | (m) | $1.73B | (m) |
| 2017-06-30 | $1.32B | (m) | $6.42B | (m) | $1.66B | (m) |
| 2017-03-31 | $1.35B | (m) | $6.34B | (m) | $1.64B | (m) |
| 2016-12-31 | $1.31B | (m) | $6.26B | (m) | $1.63B | (m) |
| 2016-09-30 | $1.23B | (m) | $6.16B | (m) | $1.62B | (m) |
| 2016-06-30 | $1.22B | (m) | $6.08B | (m) | $1.61B | (m) |
| 2016-03-31 | $1.17B | (m) | $5.97B | (m) | $1.59B | (m) |
| 2015-12-31 | $1.00B | (m) | $5.60B | (m) | $1.62B | (m) |
| 2015-09-30 | $978.50M | (m) | $5.06B | (m) | $1.53B | (m) |
| 2015-06-30 | $912.80M | (m) | $4.54B | (m) | $1.45B | (m) |
| 2015-03-31 | $837.30M | (m) | $4.07B | (m) | $1.33B | (m) |
| 2014-12-31 | $910.40M | $6.01B | $3.81B | (m) | $1.20B | 15.14% |
| 2014-09-30 | $906.40M | $5.94B | $3.75B | (m) | $1.17B | 15.27% |
| 2014-06-30 | $909.60M | $5.85B | $3.69B | (m) | $1.15B | 15.56% |
| 2014-03-31 | $932.20M | $5.80B | $3.63B | (m) | $1.13B | 16.08% |
| 2013-12-31 | $990.90M | $5.81B | $3.59B | (m) | $1.13B | 17.06% |
| 2013-09-30 | $991.20M | $5.78B | $3.54B | (m) | $1.12B | 17.16% |
| 2013-06-30 | $991.70M | $5.73B | $3.49B | (m) | $1.13B | 17.30% |
| 2013-03-31 | $998.40M | $5.69B | $3.44B | (m) | $1.13B | 17.55% |
| 2012-12-31 | $1.02B | $5.67B | $3.42B | (m) | $1.11B | 18.05% |
| 2012-09-30 | $1.06B | $5.63B | $3.37B | (m) | $1.11B | 18.74% |
| 2012-06-30 | $1.05B | $5.62B | $3.34B | (m) | $1.10B | 18.69% |
| 2012-03-31 | $999.70M | $5.60B | $3.31B | (m) | $1.15B | 17.86% |
| 2011-12-31 | $948.40M | $5.54B | $3.27B | (m) | $1.16B | 17.11% |
| 2011-09-30 | $939.70M | $5.47B | $3.22B | (m) | $1.16B | 17.17% |
| 2011-06-30 | $935.60M | $5.34B | $3.13B | (m) | $1.15B | 17.51% |
| 2011-03-31 | $980.40M | $5.18B | $3.02B | (m) | $1.07B | 18.93% |
| 2010-12-31 | $978.80M | $5.00B | $2.91B | (m) | $1.03B | 19.56% |
| 2010-09-30 | $955.80M | $4.87B | $2.83B | (m) | $1.00B | 19.61% |
| 2010-06-30 | $955.40M | $4.78B | $2.77B | (m) | $979.20M | 19.98% |
| 2010-03-31 | $929.60M | $4.73B | $2.74B | (m) | $971.10M | 19.64% |
| 2009-12-31 | $935.90M | $4.69B | $2.72B | (m) | $958.90M | 19.94% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $842.90M | $4.51B | $2.63B | (m) | $935.10M | 18.71% |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $777.00M | $4.07B | $2.38B | (m) | $808.70M | 19.10% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |